EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Proliferative ability of circulating tumor cells is a prognostic factor in Early-Stage lung adenocarcinoma

Ting-Fang Che, Chao-Hua Chiu, Yu-Chung Wu, Jia-Yang Chen, Teh-Ying Chou, Yi-Chun Cheng, Chi-Lu Chiang, Chien-Sheng Huang, I-Shuan Tuang, Yang-Hui Ho, Jian-Hua Hong, Yen-Jang Huang und 2 weitere

Lung Cancer · 2023

DOI: 10.1016/j.lungcan.2023.02.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lung Cancer, 2023. Verfasst von Ting-Fang Che und 13 weiteren Autor:innen. Beteiligte Einrichtung: Genomics Research Center, Academia Sinica, Taipei, Taiwan. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Genomics Research Center, Academia Sinica, Academia Sinica, Ministry of Science and Technology, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Circulating tumor cells (CTCs) and their proliferative ability in lung adenocarcinoma (LUAD) were not well-investigated. We developed a protocol combining an efficient viable CTC isolation and in-vitro cultivation for the CTC enumeration and proliferation to evaluate their clinical significance. METHOD: The peripheral blood of 124 treatment-naïve LUAD patients were processed by a CTC isolation microfluidics, DS platform, followed by in-vitro cultivation. LUAD-specific CTCs were defined by immunostaining of DAPI+/CD45-/(TTF1/CK7)+ and were enumerated upon isolation and after 7-day cultivation. The CTC proliferative ability was evaluated by both the cultured number and the culture index, a ratio of cultured CTC number to the initial CTC number in 2 mL of blood. RESULT: All but two LUAD patients (98.4%) were detected with at least one CTC per 2 mL of blood. Initial CTC numbers did not correlate with metastasis (75 ± 126 for non-metastatic, 87 ± 113 for metastatic groups; P = 0.203). In contrast, both the cultured CTC number (mean: 28, 104, and 185 in stage 0/I, II/III, and IV; P < 0.001), and the culture index (mean: 1.1, 1.7 and 9.3 in stage 0/I, II/III, and IV; P = 0.043) were significantly correlated with the stages. Overall survival analysis within the non-metastatic group (N = 53) showed poor prognosis for patients with elevated cultured counts (cutoff ≥ 30; P = 0.027). CONCLUSION: We implemented a CTC assay in clinical LUAD patients with a high detection rate and cultivation capability. Cultured CTC count and proliferative ability, rather than the crude CTC numbers, highly associated with cancer prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingLung NeoplasmsAdenocarcinoma of LungHumansPrognosisSurvival AnalysisBiomarkers, Tumor

Stichwörter der Autor:innen

Cell cultureCirculating tumor cellsLung adenocarcinomaMetastasisProliferative ability

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Taipei Cancer Center and Taipei Medical University Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Division of Thoracic Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei, Taiwan.
  • School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Institute of Clinical Medicine, National Yang Ming Chiao Tung…
  • School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.

Förderung

  • Genomics Research Center, Academia Sinica
  • Academia Sinica
  • Ministry of Science and Technology, Taiwan
  • Tri-Service General Hospital
  • Taipei Veterans General Hospital
  • Kaohsiung Veterans General Hospital

Zitieren

APA

Che, T. F., Chiu, C. H., Wu, Y. C., Chen, J. Y., Chou, T. Y., Cheng, Y. C., Chiang, C. L., Huang, C. S., Tuang, I. S., Ho, Y. H., Hong, J. H., Huang, Y. J., Ho, H. L., & Chang, Y. C. (2023). Proliferative ability of circulating tumor cells is a prognostic factor in Early-Stage lung adenocarcinoma. Lung Cancer. https://doi.org/10.1016/j.lungcan.2023.02.015

Vancouver

Che TF, Chiu CH, Wu YC, Chen JY, Chou TY, Cheng YC, et al. Proliferative ability of circulating tumor cells is a prognostic factor in Early-Stage lung adenocarcinoma. Lung Cancer. 2023. doi:10.1016/j.lungcan.2023.02.015

BibTeX
@article{Che2023,
  author = {Che, Ting-Fang and Chiu, Chao-Hua and Wu, Yu-Chung and Chen, Jia-Yang and Chou, Teh-Ying and Cheng, Yi-Chun and Chiang, Chi-Lu and Huang, Chien-Sheng and Tuang, I-Shuan and Ho, Yang-Hui and Hong, Jian-Hua and Huang, Yen-Jang and Ho, Hsiang-Ling and Chang, Ying-Chih},
  title = {Proliferative ability of circulating tumor cells is a prognostic factor in Early-Stage lung adenocarcinoma},
  journal = {Lung Cancer},
  year = {2023},
  doi = {10.1016/j.lungcan.2023.02.015}
}
Kostenlos starten →